Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis

International Forum of Allergy and Rhinology

Volumn 3, Issue 5, 2013, Pages 364-368

  Detwiller, Kara Y ^a   Smith, Timothy L ^a   Mace, Jess C ^a   Trune, Dennis R ^a   Sautter, Nathan B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic rhinosinusitis; Computed tomography; Matrix metalloproteinases; MMP9; Osteitis; Steroids

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ETHMOID SINUS; HUMAN; HUMAN TISSUE; MAXILLA; OSTEITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKULL RADIOGRAPHY; SPHENOID SINUS; UPREGULATION;

CHRONIC DISEASE; DISEASE PROGRESSION; ETHMOID SINUSITIS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NASAL MUCOSA; RHINITIS; STEROIDS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOMOGRAPHY, X-RAY COMPUTED; UP-REGULATION;

EID: 84878172465     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21135     Document Type: Article

References (26)

1. Pawankar R, Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep. 2007;7:202-208.
2. Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinical practice. Can Respir J. 2010;17:e85-e93.
3. Bosse Y, Pare PD, Seow CY. Airway wall remodeling in asthma: From the epithelial layer to the adventitia. Curr Allergy Asthma Rep. 2008;8:357-366.
4. Krouse JH. The unified airway-conceptual framework. Otolaryngol Clin North Am. 2008;41:257-266.
5. Bassiouni A, Naidoo Y, Wormald PJ. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease? Laryngoscope. 2012;122:225-229.
6. Chiu AG. Osteitis in chronic rhinosinusitis. Otolaryngol Clin North Am. 2005;38:1237-1242.
7. Videler WJ, Georgalas C, Menger DJ, Freling NJ, van Drunen CM, Fokkens WJ. Osteitic bone in recalcitrant chronic rhinosinusitis. Rhinology. 2011;49:139-147.
8. Wood AJ, Fraser J, Amirapu S, Douglas RG. Bacterial microcolonies exist within the sphenoid bone in chronic rhinosinusitis and healthy controls. Int Forum Allergy Rhinol. 2012;2:116-121.
9. Khalid AN, Hunt J, Perloff JR, Kennedy DW. The role of bone in chronic rhinosinusitis. Laryngoscope. 2002;112:1951-1957.
10. Jang YJ, Koo TW, Chung SY, Park SG. Bone involvement in chronic rhinosinusitis assessed by 99mTc-MDP bone SPECT. Clin Otolaryngol Allied Sci. 2002;27:156-161.
11. Bhandarkar ND, Mace JC, Smith TL. The impact of osteitis on disease severity measures and quality of life outcomes in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011;1:372-378.
12. Kostamo K, Toskala E, Tervahartiala T, Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2008;8:21-27.
13. Sautter NB, Delaney KL, Hausman FA, Trune DR. Tissue remodeling gene expression in a murine model of chronic rhinosinusitis. Laryngoscope. 2012;122:711-717.
14. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy. 2004;59:54-60.
15. Eyibilen A, Cayli S, Aladag I, Koc S, Gurbuzler L, Atay GA. Distribution of matrix metalloproteinases MMP-1, MMP-2, MMP-8 and tissue inhibitor of matrix metalloproteinases-2 in nasal polyposis and chronic rhinosinusitis. Histol Histopathol. 2011;26:615-621.
16. Bhandari A, Takeuchi K, Suzuki S, et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol. 2004;124:1165-1170.
17. Kostamo K, Tervahartiala T, Sorsa T, Richardson M, Toskala E. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2007;117:638-643.
18. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3 Suppl):S1-S31.
19. Thomas M, Yawn BP, Price D, et al. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 - a summary. Prim Care Respir J. 2008;17:79-89.
20. Lee JT, Kennedy DW, Palmer JN, Feldman M, Chiu AG. The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study. Am J Rhinol. 2006;20:278-282.
21. Wang LF, Chien CY, Tai CF, Kuo WR, Hsi E, Juo SH. Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis. BMC Med Genet. 2010;11:85.
22. Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope. 2005;115:56-61.
23. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069-1076.e4.
24. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J. 2004;23:671-678.
25. Cho SH, Min HJ, Han HX, Paik SS, Kim KR. CT analysis and histopathology of bone remodeling in patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2006;135:404-408.
26. Catalano PJ, Dolan R, Romanow J, Payne SC, Silverman M. Correlation of bone SPECT scintigraphy with histopathology of the ethmoid bulla: preliminary investigation. Ann Otol Rhinol Laryngol. 2007;116:647-652.